EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

…, R Van Vollenhoven, D Aletaha, M Aringer… - Annals of the …, 2017 - ard.bmj.com
Recent insights in rheumatoid arthritis (RA) necessitated updating the European League
Against Rheumatism (EULAR) RA management recommendations. A large international …

2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus

M Aringer, K Costenbader, D Daikh… - Arthritis & …, 2019 - Wiley Online Library
Objective To develop new classification criteria for systemic lupus erythematosus (SLE)
jointly supported by the European League Against Rheumatism (EULAR) and the American …

Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force

…, T Takeuchi, D Aletaha, JL Andreu, M Aringer… - Annals of the …, 2016 - ard.bmj.com
Background Reaching the therapeutic target of remission or low-disease activity has
improved outcomes in patients with rheumatoid arthritis (RA) significantly. The treat-to-target …

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

…, M De Wit, D Aletaha, M Aringer… - Annals of the …, 2020 - ard.bmj.com
Objectives To provide an update of the European League Against Rheumatism (EULAR)
rheumatoid arthritis (RA) management recommendations to account for the most recent …

[HTML][HTML] Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes

…, T Pettersson, J McCarthy, DM Frucht, M Aringer… - Cell, 1999 - cell.com
Autosomal dominant periodic fever syndromes are characterized by unexplained episodes
of fever and severe localized inflammation. In seven affected families, we found six different …

2019 update of the EULAR recommendations for the management of systemic lupus erythematosus

…, M Kostopoulou, A Alunno, M Aringer… - Annals of the …, 2019 - ard.bmj.com
Our objective was to update the EULAR recommendations for the management of systemic
lupus erythematosus (SLE), based on emerging new evidence. We performed a systematic …

[HTML][HTML] Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) …

…, M Tektonidou, Z Amoura, M Aringer… - Annals of the …, 2012 - ard.bmj.com
Objectives To develop recommendations for the management of adult and paediatric lupus
nephritis (LN). Methods The available evidence was systematically reviewed using the …

EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing …

GK Bertsias, JPA Ioannidis, M Aringer… - Annals of the …, 2010 - ard.bmj.com
Objectives To develop recommendations for the diagnosis, prevention and treatment of
neuropsychiatric systemic lupus erythematosus (NPSLE) manifestations. Methods The …

[HTML][HTML] Trial of tocilizumab in giant-cell arteritis

…, S Dimonaco, M Klearman, M Aringer… - … England Journal of …, 2017 - Mass Medical Soc
Background Giant-cell arteritis commonly relapses when glucocorticoids are tapered, and
the prolonged use of glucocorticoids is associated with side effects. The effect of the …

SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout

…, A Tenesa, LA Donnelly, LD Fairbanks, M Aringer… - Nature …, 2008 - nature.com
Uric acid is the end product of purine metabolism in humans and great apes, which have lost
hepatic uricase activity, leading to uniquely high serum uric acid concentrations (200–500 …